<DOC>
	<DOCNO>NCT01748799</DOCNO>
	<brief_summary>The purpose study demonstrate feasibility tolerability use Sativex cannabis dependent individual assess effect fix self titrate dosage SATIVEX® ( Δ9-tetrahydrocannabinol /cannabidiol combination buccal spray ) withdrawal symptom , crave score cannabis consumption study period .</brief_summary>
	<brief_title>Fixed Self-Titrated Dosages Sativex Cannabis Users</brief_title>
	<detailed_description>This one year pilot/feasibility study , assess effect fix self-titrated dosage SATIVEX® ( Δ9-tetrahydrocannabinol /cannabidiol combination buccal spray ) withdrawal cannabis craving among cannabis dependent subject . Subjects study undergo 8-week double-blind , placebo-controlled trial . Subjects regular cannabis-users currently seek treatment cannabis dependence . Subjects participate 8 condition , last 5 weekday ( ABACADAE study design ) ; four smoke usual condition ( SAU ) four cannabis abstinence condition . During abstinence condition ( B , C , D , E condition ) , subject allocate one condition include self-titration placebo , fix dose placebo , self-titration SATIVEX ( max 40 spray per day , equal 108mg THC ) fix dose SATIVEX ( 40 spray per day ) . Each medication phase follow washout period individual request smoke cannabis usual ( A condition ) . The experimental condition : type SATIVEX® spray use ( active v placebo ) , titration regimen ( fix self-titrated ) . This pilot study allow u demonstrate feasibility approach determine sample size use secondarily large study . Our ultimate goal determine optimal condition use subsequent randomized control trial assess efficacy SATIVEX® treatment Cannabis dependence among treatment-seeking subject .</detailed_description>
	<mesh_term>Marijuana Abuse</mesh_term>
	<mesh_term>Dronabinol</mesh_term>
	<mesh_term>Peppermint oil</mesh_term>
	<criteria>age 1850 current cannabis dependence cannabis primary drug abuse frequent cannabis use ( i.e. , least 5 day per week ) experience least 2 withdrawal symptom previous cessation period cannabis use medical purpose ( i.e. , governmentlicensed medical cannabis user ) seek treatment cannabis dependence willingness participate study protocol meet criterion psychiatric disorder require psychiatric intervention history seizure ; c ) know sensitivity Dronabinol , Cannabidiol , Propylene glycole , Ethanol peppermint oil ( use Sativex buccal spray suffer unstable medical condition currently physical dependence drug ( exclude nicotine ) would require medical detoxification currently take psychotropic medication benefit illness treatment insomnia pregnant breastfeeding hold job involve operate heavy machinery currently seek treatment cannabisrelated problem family history psychotic symptom</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Cannabis dependence</keyword>
	<keyword>Sativex</keyword>
</DOC>